USPTO serial 79296099
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Stem cells for research and scientific purposes; stem cells, other than for medical or veterinary purposes; industrial chemicals; chemical test paper, other than for medical purposes; cell culture reagents for laboratory use; cell culture media for scientific or research purposes; biological preparation for use in cell cultures other than for medical or veterinary use | ACTIVE | — |
| 005 | Stem cells for medical and clinical purposes; pharmaceutical preparations for use in regenerative therapy; test paper being reagent paper for medical purposes; living cells for medical use; cells for medical use; tissues for medical use, namely, biological tissue cultures for medical purposes | ACTIVE | — |
| 039 | Storage of frozen living cells; storage of biological tissues, cells and stem cells; warehousing services for deposited articles | ACTIVE | — |
| 042 | Scientific research on stem cells; cell culture services for scientific and research purposes, for others; cytogenetic examination for research purposes; scientific testing, examination for medical research purposes, research and development in the field of cytology; scientific testing, examination for medical research purposes, research and development in the field of regenerative medicine; testing, examination, research and development of pharmaceuticals; conducting clinical studies for others; medical laboratory services; providing quality assurance in the field of cells; quality control for others; providing information on medical research in the field of medical therapy; providing information on medical research and testing for medical research purposes related to stem cells; providing information related to research and development of pharmaceutical preparations; scientific testing, examination for medical research purposes and research of medical therapy methods and technologies; testing, examination and research of cosmetics and foods; design and development of computer hardware and computer software for use in the field of medical science; design and development of machines, apparatus, instruments and systems in the field of medical science; design, development and maintenance of computer programs; testing the functionality of and performing research on machines, apparatus, and instruments in the field of medical science; rental of laboratory apparatus and instruments | ACTIVE | — |
| 044 | Stem cell therapy services; providing medical information in the field of cells; providing medical information on regenerative medicine; providing medical information; collection and preservation of biological tissues, blood and cells; medical treatment and diagnosis services in the nature of regenerative therapy by using a cell culture ; cell culture bank services for medical transplantation ; medical care; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis in the nature of regenerative therapy by regenerative medicine; medical cell therapy and diagnosis services in the nature of regenerative cell therapy; medical treatment and consulting services in the nature of regenerative cell therapy by cell preparations; preservation of human blood for stem cells; providing medical information and medical record analysis for use in medical treatment ; clinical medical examination services; providing health care services; preparation and dispensing of medications; physical examination services; dentistry services; providing health information; dietary and nutritional guidance; rental of medical apparatus and instruments | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 6, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 12, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 11, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Feb 23, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Nov 26, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 5, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 18, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 18, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 18, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 2, 2021 | ALIE | ASSIGNED TO LIE | — |
| Aug 2, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 2, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 2, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 2, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 2, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 14, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 14, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 1, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 7, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 7, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 29, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 23, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 19, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 19, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 15, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |